nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—Barrett's esophagus—head and neck cancer	0.571	1	CtDrD
Omeprazole—CYP1A1—head and neck cancer	0.178	1	CbGaD
Omeprazole—ABCC3—Fluorouracil—head and neck cancer	0.0485	0.262	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—head and neck cancer	0.032	0.173	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—head and neck cancer	0.0199	0.108	CbGbCtD
Omeprazole—CYP2D6—Hydroxyurea—head and neck cancer	0.0177	0.0956	CbGbCtD
Omeprazole—ABCG2—Docetaxel—head and neck cancer	0.0152	0.0821	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—head and neck cancer	0.0106	0.0573	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—head and neck cancer	0.00822	0.0443	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—head and neck cancer	0.00741	0.04	CbGbCtD
Omeprazole—ABCB1—Vinblastine—head and neck cancer	0.00666	0.0359	CbGbCtD
Omeprazole—CYP2D6—Vinblastine—head and neck cancer	0.00628	0.0338	CbGbCtD
Omeprazole—ABCB1—Docetaxel—head and neck cancer	0.00549	0.0296	CbGbCtD
Omeprazole—CYP3A4—Vinblastine—head and neck cancer	0.00399	0.0215	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—head and neck cancer	0.00329	0.0177	CbGbCtD
Omeprazole—ATP4A—larynx—head and neck cancer	0.00114	0.306	CbGeAlD
Omeprazole—Rabeprazole—CYP1A1—head and neck cancer	0.000636	0.573	CrCbGaD
Omeprazole—Lansoprazole—CYP1A1—head and neck cancer	0.000474	0.427	CrCbGaD
Omeprazole—ATP4A—neck—head and neck cancer	0.000303	0.0812	CbGeAlD
Omeprazole—Rash erythematous—Docetaxel—head and neck cancer	0.000223	0.00633	CcSEcCtD
Omeprazole—Angina pectoris—Vinblastine—head and neck cancer	0.000221	0.00625	CcSEcCtD
Omeprazole—Otitis media—Docetaxel—head and neck cancer	0.00022	0.00622	CcSEcCtD
Omeprazole—Necrosis—Docetaxel—head and neck cancer	0.000218	0.00617	CcSEcCtD
Omeprazole—ATP4A—connective tissue—head and neck cancer	0.000217	0.0582	CbGeAlD
Omeprazole—Oesophagitis—Fluorouracil—head and neck cancer	0.000217	0.00613	CcSEcCtD
Omeprazole—Breast disorder—Hydroxyurea—head and neck cancer	0.000216	0.00612	CcSEcCtD
Omeprazole—Rash maculo-papular—Fluorouracil—head and neck cancer	0.000215	0.0061	CcSEcCtD
Omeprazole—Pancytopenia—Vinblastine—head and neck cancer	0.000215	0.00609	CcSEcCtD
Omeprazole—Ageusia—Docetaxel—head and neck cancer	0.000211	0.00598	CcSEcCtD
Omeprazole—Rigors—Docetaxel—head and neck cancer	0.00021	0.00593	CcSEcCtD
Omeprazole—ATP4A—epithelium—head and neck cancer	0.000206	0.0552	CbGeAlD
Omeprazole—Pancreatitis—Hydroxyurea—head and neck cancer	0.000203	0.00574	CcSEcCtD
Omeprazole—Depression—Vinblastine—head and neck cancer	0.000201	0.0057	CcSEcCtD
Omeprazole—Eye irritation—Docetaxel—head and neck cancer	0.0002	0.00567	CcSEcCtD
Omeprazole—Pancytopenia—Hydroxyurea—head and neck cancer	0.000196	0.00556	CcSEcCtD
Omeprazole—Photosensitivity—Fluorouracil—head and neck cancer	0.000196	0.00555	CcSEcCtD
Omeprazole—Swelling—Fluorouracil—head and neck cancer	0.000195	0.00552	CcSEcCtD
Omeprazole—Neutropenia—Hydroxyurea—head and neck cancer	0.000193	0.00547	CcSEcCtD
Omeprazole—Dysuria—Hydroxyurea—head and neck cancer	0.000193	0.00547	CcSEcCtD
Omeprazole—Bone disorder—Docetaxel—head and neck cancer	0.000189	0.00536	CcSEcCtD
Omeprazole—Agranulocytosis—Vinblastine—head and neck cancer	0.000189	0.00534	CcSEcCtD
Omeprazole—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000188	0.00533	CcSEcCtD
Omeprazole—Weight increased—Hydroxyurea—head and neck cancer	0.000188	0.00532	CcSEcCtD
Omeprazole—Infestation NOS—Hydroxyurea—head and neck cancer	0.000184	0.00522	CcSEcCtD
Omeprazole—Infestation—Hydroxyurea—head and neck cancer	0.000184	0.00522	CcSEcCtD
Omeprazole—Hypoaesthesia—Vinblastine—head and neck cancer	0.00018	0.00511	CcSEcCtD
Omeprazole—Pharyngitis—Vinblastine—head and neck cancer	0.00018	0.0051	CcSEcCtD
Omeprazole—CYP1B1—hair follicle—head and neck cancer	0.00018	0.0482	CbGeAlD
Omeprazole—Stomatitis—Hydroxyurea—head and neck cancer	0.00018	0.00508	CcSEcCtD
Omeprazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000174	0.00493	CcSEcCtD
Omeprazole—Osteoarthritis—Fluorouracil—head and neck cancer	0.000172	0.00487	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000172	0.00487	CcSEcCtD
Omeprazole—Hepatocellular injury—Docetaxel—head and neck cancer	0.000171	0.00484	CcSEcCtD
Omeprazole—Blood pressure increased—Docetaxel—head and neck cancer	0.000171	0.00484	CcSEcCtD
Omeprazole—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000171	0.00484	CcSEcCtD
Omeprazole—Injection site reaction—Docetaxel—head and neck cancer	0.00017	0.00482	CcSEcCtD
Omeprazole—Hallucination—Hydroxyurea—head and neck cancer	0.000165	0.00466	CcSEcCtD
Omeprazole—Irritability—Fluorouracil—head and neck cancer	0.000164	0.00465	CcSEcCtD
Omeprazole—Candida infection—Docetaxel—head and neck cancer	0.000163	0.00462	CcSEcCtD
Omeprazole—Fluid retention—Docetaxel—head and neck cancer	0.000162	0.0046	CcSEcCtD
Omeprazole—Alopecia—Vinblastine—head and neck cancer	0.00016	0.00454	CcSEcCtD
Omeprazole—Dry skin—Fluorouracil—head and neck cancer	0.000158	0.00447	CcSEcCtD
Omeprazole—Oesophagitis—Docetaxel—head and neck cancer	0.000156	0.00443	CcSEcCtD
Omeprazole—Neoplasm—Docetaxel—head and neck cancer	0.000155	0.00438	CcSEcCtD
Omeprazole—Lightheadedness—Docetaxel—head and neck cancer	0.000153	0.00433	CcSEcCtD
Omeprazole—Muscular weakness—Fluorouracil—head and neck cancer	0.000152	0.0043	CcSEcCtD
Omeprazole—Dysphagia—Fluorouracil—head and neck cancer	0.000149	0.00421	CcSEcCtD
Omeprazole—Chills—Hydroxyurea—head and neck cancer	0.000148	0.0042	CcSEcCtD
Omeprazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.000146	0.00415	CcSEcCtD
Omeprazole—Alopecia—Hydroxyurea—head and neck cancer	0.000146	0.00414	CcSEcCtD
Omeprazole—Anaemia—Vinblastine—head and neck cancer	0.000146	0.00413	CcSEcCtD
Omeprazole—Angina pectoris—Fluorouracil—head and neck cancer	0.000145	0.0041	CcSEcCtD
Omeprazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000143	0.00404	CcSEcCtD
Omeprazole—Malaise—Vinblastine—head and neck cancer	0.000142	0.00403	CcSEcCtD
Omeprazole—CYP11A1—connective tissue—head and neck cancer	0.000142	0.0381	CbGeAlD
Omeprazole—Vertigo—Vinblastine—head and neck cancer	0.000142	0.00402	CcSEcCtD
Omeprazole—Leukopenia—Vinblastine—head and neck cancer	0.000141	0.004	CcSEcCtD
Omeprazole—Pancytopenia—Fluorouracil—head and neck cancer	0.000141	0.004	CcSEcCtD
Omeprazole—Swelling—Docetaxel—head and neck cancer	0.000141	0.00399	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000138	0.00391	CcSEcCtD
Omeprazole—Hepatic failure—Docetaxel—head and neck cancer	0.000138	0.00391	CcSEcCtD
Omeprazole—Hypertension—Vinblastine—head and neck cancer	0.000136	0.00386	CcSEcCtD
Omeprazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000136	0.00384	CcSEcCtD
Omeprazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000134	0.00378	CcSEcCtD
Omeprazole—Anaemia—Hydroxyurea—head and neck cancer	0.000133	0.00377	CcSEcCtD
Omeprazole—Discomfort—Vinblastine—head and neck cancer	0.000133	0.00376	CcSEcCtD
Omeprazole—Hot flush—Docetaxel—head and neck cancer	0.000133	0.00376	CcSEcCtD
Omeprazole—Infestation NOS—Fluorouracil—head and neck cancer	0.000133	0.00375	CcSEcCtD
Omeprazole—Infestation—Fluorouracil—head and neck cancer	0.000133	0.00375	CcSEcCtD
Omeprazole—Menopausal symptoms—Docetaxel—head and neck cancer	0.000132	0.00373	CcSEcCtD
Omeprazole—Visual disturbance—Docetaxel—head and neck cancer	0.000131	0.00371	CcSEcCtD
Omeprazole—Renal impairment—Docetaxel—head and neck cancer	0.00013	0.00369	CcSEcCtD
Omeprazole—Malaise—Hydroxyurea—head and neck cancer	0.00013	0.00368	CcSEcCtD
Omeprazole—Stomatitis—Fluorouracil—head and neck cancer	0.000129	0.00366	CcSEcCtD
Omeprazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.000129	0.00365	CcSEcCtD
Omeprazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.000129	0.00365	CcSEcCtD
Omeprazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000129	0.00365	CcSEcCtD
Omeprazole—ATP4A—head—head and neck cancer	0.000128	0.0343	CbGeAlD
Omeprazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000126	0.00357	CcSEcCtD
Omeprazole—Epistaxis—Fluorouracil—head and neck cancer	0.000125	0.00354	CcSEcCtD
Omeprazole—Hyponatraemia—Docetaxel—head and neck cancer	0.000125	0.00353	CcSEcCtD
Omeprazole—Sinusitis—Fluorouracil—head and neck cancer	0.000124	0.00352	CcSEcCtD
Omeprazole—Pain in extremity—Docetaxel—head and neck cancer	0.000124	0.00352	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000124	0.00352	CcSEcCtD
Omeprazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000124	0.0035	CcSEcCtD
Omeprazole—Anorexia—Vinblastine—head and neck cancer	0.000123	0.00348	CcSEcCtD
Omeprazole—Migraine—Docetaxel—head and neck cancer	0.000122	0.00346	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000122	0.00345	CcSEcCtD
Omeprazole—Discomfort—Hydroxyurea—head and neck cancer	0.000121	0.00343	CcSEcCtD
Omeprazole—Rhinitis—Fluorouracil—head and neck cancer	0.000119	0.00338	CcSEcCtD
Omeprazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000118	0.00335	CcSEcCtD
Omeprazole—Pharyngitis—Fluorouracil—head and neck cancer	0.000118	0.00335	CcSEcCtD
Omeprazole—Infection—Hydroxyurea—head and neck cancer	0.000117	0.0033	CcSEcCtD
Omeprazole—Paraesthesia—Vinblastine—head and neck cancer	0.000116	0.00328	CcSEcCtD
Omeprazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000115	0.00326	CcSEcCtD
Omeprazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000115	0.00326	CcSEcCtD
Omeprazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000114	0.00323	CcSEcCtD
Omeprazole—Dry skin—Docetaxel—head and neck cancer	0.000114	0.00322	CcSEcCtD
Omeprazole—Abdominal pain upper—Docetaxel—head and neck cancer	0.000113	0.00321	CcSEcCtD
Omeprazole—Breast disorder—Docetaxel—head and neck cancer	0.000112	0.00318	CcSEcCtD
Omeprazole—Anorexia—Hydroxyurea—head and neck cancer	0.000112	0.00317	CcSEcCtD
Omeprazole—Decreased appetite—Vinblastine—head and neck cancer	0.000112	0.00317	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000112	0.00317	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000112	0.00317	CcSEcCtD
Omeprazole—Cramp muscle—Docetaxel—head and neck cancer	0.000112	0.00317	CcSEcCtD
Omeprazole—Pain—Vinblastine—head and neck cancer	0.00011	0.00312	CcSEcCtD
Omeprazole—Constipation—Vinblastine—head and neck cancer	0.00011	0.00312	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00011	0.0031	CcSEcCtD
Omeprazole—Dysphagia—Docetaxel—head and neck cancer	0.000107	0.00304	CcSEcCtD
Omeprazole—Feeling abnormal—Vinblastine—head and neck cancer	0.000106	0.00301	CcSEcCtD
Omeprazole—Bronchospasm—Docetaxel—head and neck cancer	0.000106	0.00299	CcSEcCtD
Omeprazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000105	0.00298	CcSEcCtD
Omeprazole—Alopecia—Fluorouracil—head and neck cancer	0.000105	0.00298	CcSEcCtD
Omeprazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000105	0.00297	CcSEcCtD
Omeprazole—Angina pectoris—Docetaxel—head and neck cancer	0.000105	0.00296	CcSEcCtD
Omeprazole—Somnolence—Hydroxyurea—head and neck cancer	0.000104	0.00296	CcSEcCtD
Omeprazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000103	0.00293	CcSEcCtD
Omeprazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000102	0.00289	CcSEcCtD
Omeprazole—Pancytopenia—Docetaxel—head and neck cancer	0.000102	0.00289	CcSEcCtD
Omeprazole—Abdominal pain—Vinblastine—head and neck cancer	0.000102	0.00288	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000101	0.00287	CcSEcCtD
Omeprazole—Fatigue—Hydroxyurea—head and neck cancer	0.000101	0.00287	CcSEcCtD
Omeprazole—Pain—Hydroxyurea—head and neck cancer	0.0001	0.00284	CcSEcCtD
Omeprazole—Constipation—Hydroxyurea—head and neck cancer	0.0001	0.00284	CcSEcCtD
Omeprazole—Neutropenia—Docetaxel—head and neck cancer	0.0001	0.00284	CcSEcCtD
Omeprazole—CYP1A1—mouth—head and neck cancer	9.97e-05	0.0267	CbGeAlD
Omeprazole—Weight increased—Docetaxel—head and neck cancer	9.77e-05	0.00277	CcSEcCtD
Omeprazole—Vision blurred—Fluorouracil—head and neck cancer	9.77e-05	0.00277	CcSEcCtD
Omeprazole—Weight decreased—Docetaxel—head and neck cancer	9.71e-05	0.00275	CcSEcCtD
Omeprazole—Feeling abnormal—Hydroxyurea—head and neck cancer	9.68e-05	0.00274	CcSEcCtD
Omeprazole—Anaemia—Fluorouracil—head and neck cancer	9.58e-05	0.00271	CcSEcCtD
Omeprazole—Infestation—Docetaxel—head and neck cancer	9.57e-05	0.00271	CcSEcCtD
Omeprazole—Infestation NOS—Docetaxel—head and neck cancer	9.57e-05	0.00271	CcSEcCtD
Omeprazole—Hypersensitivity—Vinblastine—head and neck cancer	9.49e-05	0.00269	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	9.49e-05	0.00269	CcSEcCtD
Omeprazole—Renal failure—Docetaxel—head and neck cancer	9.41e-05	0.00266	CcSEcCtD
Omeprazole—Stomatitis—Docetaxel—head and neck cancer	9.33e-05	0.00264	CcSEcCtD
Omeprazole—Jaundice—Docetaxel—head and neck cancer	9.33e-05	0.00264	CcSEcCtD
Omeprazole—Conjunctivitis—Docetaxel—head and neck cancer	9.3e-05	0.00263	CcSEcCtD
Omeprazole—Body temperature increased—Hydroxyurea—head and neck cancer	9.29e-05	0.00263	CcSEcCtD
Omeprazole—Leukopenia—Fluorouracil—head and neck cancer	9.28e-05	0.00263	CcSEcCtD
Omeprazole—Asthenia—Vinblastine—head and neck cancer	9.24e-05	0.00262	CcSEcCtD
Omeprazole—Hepatobiliary disease—Docetaxel—head and neck cancer	9.05e-05	0.00256	CcSEcCtD
Omeprazole—Epistaxis—Docetaxel—head and neck cancer	9.03e-05	0.00256	CcSEcCtD
Omeprazole—Agranulocytosis—Docetaxel—head and neck cancer	8.93e-05	0.00253	CcSEcCtD
Omeprazole—Myalgia—Fluorouracil—head and neck cancer	8.82e-05	0.0025	CcSEcCtD
Omeprazole—Chest pain—Fluorouracil—head and neck cancer	8.82e-05	0.0025	CcSEcCtD
Omeprazole—Diarrhoea—Vinblastine—head and neck cancer	8.81e-05	0.0025	CcSEcCtD
Omeprazole—Discomfort—Fluorouracil—head and neck cancer	8.72e-05	0.00247	CcSEcCtD
Omeprazole—Hypersensitivity—Hydroxyurea—head and neck cancer	8.66e-05	0.00245	CcSEcCtD
Omeprazole—CYP1B1—connective tissue—head and neck cancer	8.64e-05	0.0232	CbGeAlD
Omeprazole—Rhinitis—Docetaxel—head and neck cancer	8.61e-05	0.00244	CcSEcCtD
Omeprazole—Hepatitis—Docetaxel—head and neck cancer	8.59e-05	0.00243	CcSEcCtD
Omeprazole—Hypoaesthesia—Docetaxel—head and neck cancer	8.55e-05	0.00242	CcSEcCtD
Omeprazole—Confusional state—Fluorouracil—head and neck cancer	8.53e-05	0.00241	CcSEcCtD
Omeprazole—Pharyngitis—Docetaxel—head and neck cancer	8.53e-05	0.00241	CcSEcCtD
Omeprazole—Dizziness—Vinblastine—head and neck cancer	8.52e-05	0.00241	CcSEcCtD
Omeprazole—Urinary tract disorder—Docetaxel—head and neck cancer	8.48e-05	0.0024	CcSEcCtD
Omeprazole—Oedema peripheral—Docetaxel—head and neck cancer	8.46e-05	0.0024	CcSEcCtD
Omeprazole—Anaphylactic shock—Fluorouracil—head and neck cancer	8.46e-05	0.00239	CcSEcCtD
Omeprazole—Connective tissue disorder—Docetaxel—head and neck cancer	8.44e-05	0.00239	CcSEcCtD
Omeprazole—Asthenia—Hydroxyurea—head and neck cancer	8.43e-05	0.00239	CcSEcCtD
Omeprazole—Urethral disorder—Docetaxel—head and neck cancer	8.42e-05	0.00238	CcSEcCtD
Omeprazole—Infection—Fluorouracil—head and neck cancer	8.4e-05	0.00238	CcSEcCtD
Omeprazole—CYP11A1—head—head and neck cancer	8.38e-05	0.0225	CbGeAlD
Omeprazole—Nervous system disorder—Fluorouracil—head and neck cancer	8.29e-05	0.00235	CcSEcCtD
Omeprazole—Thrombocytopenia—Fluorouracil—head and neck cancer	8.28e-05	0.00234	CcSEcCtD
Omeprazole—Visual impairment—Docetaxel—head and neck cancer	8.28e-05	0.00234	CcSEcCtD
Omeprazole—Tachycardia—Fluorouracil—head and neck cancer	8.25e-05	0.00234	CcSEcCtD
Omeprazole—Vomiting—Vinblastine—head and neck cancer	8.19e-05	0.00232	CcSEcCtD
Omeprazole—Erythema multiforme—Docetaxel—head and neck cancer	8.12e-05	0.0023	CcSEcCtD
Omeprazole—Headache—Vinblastine—head and neck cancer	8.07e-05	0.00229	CcSEcCtD
Omeprazole—Anorexia—Fluorouracil—head and neck cancer	8.06e-05	0.00228	CcSEcCtD
Omeprazole—Diarrhoea—Hydroxyurea—head and neck cancer	8.04e-05	0.00228	CcSEcCtD
Omeprazole—Eye disorder—Docetaxel—head and neck cancer	8.03e-05	0.00227	CcSEcCtD
Omeprazole—Flushing—Docetaxel—head and neck cancer	7.97e-05	0.00226	CcSEcCtD
Omeprazole—Dizziness—Hydroxyurea—head and neck cancer	7.77e-05	0.0022	CcSEcCtD
Omeprazole—Immune system disorder—Docetaxel—head and neck cancer	7.76e-05	0.0022	CcSEcCtD
Omeprazole—Mediastinal disorder—Docetaxel—head and neck cancer	7.74e-05	0.00219	CcSEcCtD
Omeprazole—Chills—Docetaxel—head and neck cancer	7.71e-05	0.00218	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	7.7e-05	0.00218	CcSEcCtD
Omeprazole—Nausea—Vinblastine—head and neck cancer	7.65e-05	0.00217	CcSEcCtD
Omeprazole—Insomnia—Fluorouracil—head and neck cancer	7.65e-05	0.00217	CcSEcCtD
Omeprazole—Paraesthesia—Fluorouracil—head and neck cancer	7.59e-05	0.00215	CcSEcCtD
Omeprazole—Alopecia—Docetaxel—head and neck cancer	7.59e-05	0.00215	CcSEcCtD
Omeprazole—Dyspnoea—Fluorouracil—head and neck cancer	7.54e-05	0.00213	CcSEcCtD
Omeprazole—Mental disorder—Docetaxel—head and neck cancer	7.53e-05	0.00213	CcSEcCtD
Omeprazole—Somnolence—Fluorouracil—head and neck cancer	7.52e-05	0.00213	CcSEcCtD
Omeprazole—Malnutrition—Docetaxel—head and neck cancer	7.48e-05	0.00212	CcSEcCtD
Omeprazole—Vomiting—Hydroxyurea—head and neck cancer	7.47e-05	0.00212	CcSEcCtD
Omeprazole—Dyspepsia—Fluorouracil—head and neck cancer	7.44e-05	0.00211	CcSEcCtD
Omeprazole—Rash—Hydroxyurea—head and neck cancer	7.41e-05	0.0021	CcSEcCtD
Omeprazole—Dermatitis—Hydroxyurea—head and neck cancer	7.4e-05	0.0021	CcSEcCtD
Omeprazole—Headache—Hydroxyurea—head and neck cancer	7.36e-05	0.00208	CcSEcCtD
Omeprazole—Decreased appetite—Fluorouracil—head and neck cancer	7.35e-05	0.00208	CcSEcCtD
Omeprazole—ABCC3—thyroid gland—head and neck cancer	7.34e-05	0.0197	CbGeAlD
Omeprazole—Dysgeusia—Docetaxel—head and neck cancer	7.32e-05	0.00207	CcSEcCtD
Omeprazole—ABCG2—parotid gland—head and neck cancer	7.31e-05	0.0196	CbGeAlD
Omeprazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	7.3e-05	0.00207	CcSEcCtD
Omeprazole—Back pain—Docetaxel—head and neck cancer	7.23e-05	0.00205	CcSEcCtD
Omeprazole—Pain—Fluorouracil—head and neck cancer	7.23e-05	0.00205	CcSEcCtD
Omeprazole—Muscle spasms—Docetaxel—head and neck cancer	7.19e-05	0.00204	CcSEcCtD
Omeprazole—ABCG2—saliva-secreting gland—head and neck cancer	7e-05	0.0188	CbGeAlD
Omeprazole—Nausea—Hydroxyurea—head and neck cancer	6.98e-05	0.00198	CcSEcCtD
Omeprazole—Feeling abnormal—Fluorouracil—head and neck cancer	6.97e-05	0.00197	CcSEcCtD
Omeprazole—CYP1A1—parotid gland—head and neck cancer	6.94e-05	0.0186	CbGeAlD
Omeprazole—Anaemia—Docetaxel—head and neck cancer	6.91e-05	0.00196	CcSEcCtD
Omeprazole—Urticaria—Fluorouracil—head and neck cancer	6.72e-05	0.0019	CcSEcCtD
Omeprazole—Leukopenia—Docetaxel—head and neck cancer	6.69e-05	0.0019	CcSEcCtD
Omeprazole—Body temperature increased—Fluorouracil—head and neck cancer	6.69e-05	0.00189	CcSEcCtD
Omeprazole—Palpitations—Docetaxel—head and neck cancer	6.61e-05	0.00187	CcSEcCtD
Omeprazole—Cough—Docetaxel—head and neck cancer	6.53e-05	0.00185	CcSEcCtD
Omeprazole—ABCC3—head—head and neck cancer	6.51e-05	0.0174	CbGeAlD
Omeprazole—Hypertension—Docetaxel—head and neck cancer	6.46e-05	0.00183	CcSEcCtD
Omeprazole—Myalgia—Docetaxel—head and neck cancer	6.37e-05	0.0018	CcSEcCtD
Omeprazole—Arthralgia—Docetaxel—head and neck cancer	6.37e-05	0.0018	CcSEcCtD
Omeprazole—Chest pain—Docetaxel—head and neck cancer	6.37e-05	0.0018	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	6.32e-05	0.00179	CcSEcCtD
Omeprazole—CYP1B1—lymphoid tissue—head and neck cancer	6.32e-05	0.0169	CbGeAlD
Omeprazole—Hypersensitivity—Fluorouracil—head and neck cancer	6.23e-05	0.00176	CcSEcCtD
Omeprazole—Dry mouth—Docetaxel—head and neck cancer	6.23e-05	0.00176	CcSEcCtD
Omeprazole—Confusional state—Docetaxel—head and neck cancer	6.15e-05	0.00174	CcSEcCtD
Omeprazole—Anaphylactic shock—Docetaxel—head and neck cancer	6.1e-05	0.00173	CcSEcCtD
Omeprazole—Infection—Docetaxel—head and neck cancer	6.06e-05	0.00172	CcSEcCtD
Omeprazole—Shock—Docetaxel—head and neck cancer	6.01e-05	0.0017	CcSEcCtD
Omeprazole—Nervous system disorder—Docetaxel—head and neck cancer	5.99e-05	0.00169	CcSEcCtD
Omeprazole—Pruritus—Fluorouracil—head and neck cancer	5.98e-05	0.00169	CcSEcCtD
Omeprazole—Thrombocytopenia—Docetaxel—head and neck cancer	5.98e-05	0.00169	CcSEcCtD
Omeprazole—Tachycardia—Docetaxel—head and neck cancer	5.96e-05	0.00169	CcSEcCtD
Omeprazole—Skin disorder—Docetaxel—head and neck cancer	5.93e-05	0.00168	CcSEcCtD
Omeprazole—CYP11A1—lymph node—head and neck cancer	5.87e-05	0.0157	CbGeAlD
Omeprazole—Anorexia—Docetaxel—head and neck cancer	5.82e-05	0.00165	CcSEcCtD
Omeprazole—CYP1A1—epithelium—head and neck cancer	5.8e-05	0.0155	CbGeAlD
Omeprazole—Diarrhoea—Fluorouracil—head and neck cancer	5.79e-05	0.00164	CcSEcCtD
Omeprazole—CYP1B1—thyroid gland—head and neck cancer	5.74e-05	0.0154	CbGeAlD
Omeprazole—Dizziness—Fluorouracil—head and neck cancer	5.59e-05	0.00158	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	5.56e-05	0.00157	CcSEcCtD
Omeprazole—Insomnia—Docetaxel—head and neck cancer	5.52e-05	0.00156	CcSEcCtD
Omeprazole—Paraesthesia—Docetaxel—head and neck cancer	5.48e-05	0.00155	CcSEcCtD
Omeprazole—Dyspnoea—Docetaxel—head and neck cancer	5.44e-05	0.00154	CcSEcCtD
Omeprazole—Somnolence—Docetaxel—head and neck cancer	5.43e-05	0.00154	CcSEcCtD
Omeprazole—Vomiting—Fluorouracil—head and neck cancer	5.38e-05	0.00152	CcSEcCtD
Omeprazole—Dyspepsia—Docetaxel—head and neck cancer	5.37e-05	0.00152	CcSEcCtD
Omeprazole—Rash—Fluorouracil—head and neck cancer	5.33e-05	0.00151	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—head and neck cancer	5.33e-05	0.00151	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—head and neck cancer	5.31e-05	0.0015	CcSEcCtD
Omeprazole—Headache—Fluorouracil—head and neck cancer	5.3e-05	0.0015	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	5.27e-05	0.00149	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—head and neck cancer	5.26e-05	0.00149	CcSEcCtD
Omeprazole—Pain—Docetaxel—head and neck cancer	5.22e-05	0.00148	CcSEcCtD
Omeprazole—Constipation—Docetaxel—head and neck cancer	5.22e-05	0.00148	CcSEcCtD
Omeprazole—CYP1A1—trachea—head and neck cancer	5.13e-05	0.0137	CbGeAlD
Omeprazole—CYP1B1—head—head and neck cancer	5.09e-05	0.0136	CbGeAlD
Omeprazole—Feeling abnormal—Docetaxel—head and neck cancer	5.03e-05	0.00142	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—head and neck cancer	5.02e-05	0.00142	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—head and neck cancer	4.99e-05	0.00141	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—head and neck cancer	4.83e-05	0.00137	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—head and neck cancer	4.83e-05	0.00137	CcSEcCtD
Omeprazole—ABCC3—lymph node—head and neck cancer	4.56e-05	0.0122	CbGeAlD
Omeprazole—Hypersensitivity—Docetaxel—head and neck cancer	4.5e-05	0.00127	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—head and neck cancer	4.38e-05	0.00124	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—head and neck cancer	4.32e-05	0.00122	CcSEcCtD
Omeprazole—ABCG2—thyroid gland—head and neck cancer	4.27e-05	0.0115	CbGeAlD
Omeprazole—Diarrhoea—Docetaxel—head and neck cancer	4.18e-05	0.00118	CcSEcCtD
Omeprazole—CYP1A2—thyroid gland—head and neck cancer	4.11e-05	0.011	CbGeAlD
Omeprazole—CYP1A1—thyroid gland—head and neck cancer	4.06e-05	0.0109	CbGeAlD
Omeprazole—Dizziness—Docetaxel—head and neck cancer	4.04e-05	0.00114	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—head and neck cancer	3.88e-05	0.0011	CcSEcCtD
Omeprazole—Rash—Docetaxel—head and neck cancer	3.85e-05	0.00109	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—head and neck cancer	3.84e-05	0.00109	CcSEcCtD
Omeprazole—Headache—Docetaxel—head and neck cancer	3.82e-05	0.00108	CcSEcCtD
Omeprazole—Nausea—Docetaxel—head and neck cancer	3.63e-05	0.00103	CcSEcCtD
Omeprazole—CYP1A1—head—head and neck cancer	3.6e-05	0.00965	CbGeAlD
Omeprazole—CYP1B1—lymph node—head and neck cancer	3.57e-05	0.00956	CbGeAlD
Omeprazole—ABCB1—epithelium—head and neck cancer	3.01e-05	0.00807	CbGeAlD
Omeprazole—ABCB1—trachea—head and neck cancer	2.66e-05	0.00714	CbGeAlD
Omeprazole—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	2.66e-05	0.00104	CbGpPWpGaD
Omeprazole—ABCG2—lymph node—head and neck cancer	2.66e-05	0.00712	CbGeAlD
Omeprazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	2.65e-05	0.00103	CbGpPWpGaD
Omeprazole—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	2.62e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.61e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP2D6—head—head and neck cancer	2.6e-05	0.00697	CbGeAlD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	2.57e-05	0.001	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	2.54e-05	0.000992	CbGpPWpGaD
Omeprazole—CYP1A1—lymph node—head and neck cancer	2.52e-05	0.00676	CbGeAlD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.49e-05	0.00097	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.46e-05	0.00096	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.45e-05	0.000955	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	2.44e-05	0.00095	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	2.4e-05	0.000937	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.39e-05	0.000933	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—NAT2—head and neck cancer	2.34e-05	0.000913	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.33e-05	0.00091	CbGpPWpGaD
Omeprazole—ABCB1—lymphoid tissue—head and neck cancer	2.32e-05	0.00622	CbGeAlD
Omeprazole—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	2.31e-05	0.000901	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	2.28e-05	0.000888	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—UROD—head and neck cancer	2.22e-05	0.000864	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	2.17e-05	0.000848	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	2.16e-05	0.000843	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	2.14e-05	0.000836	CbGpPWpGaD
Omeprazole—ABCB1—thyroid gland—head and neck cancer	2.11e-05	0.00565	CbGeAlD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.09e-05	0.000816	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.07e-05	0.000808	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2—head and neck cancer	2.07e-05	0.000806	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	2.06e-05	0.000804	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—DPYD—head and neck cancer	2.05e-05	0.000801	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	2.03e-05	0.000793	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—UROD—head and neck cancer	2.03e-05	0.000792	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	2.03e-05	0.000791	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NAT2—head and neck cancer	2.03e-05	0.00079	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	2e-05	0.00078	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.98e-05	0.000774	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	1.98e-05	0.000773	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.97e-05	0.00077	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	1.97e-05	0.000769	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NAT2—head and neck cancer	1.97e-05	0.000769	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	1.96e-05	0.000763	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—YAP1—head and neck cancer	1.95e-05	0.00076	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	1.95e-05	0.000759	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	1.94e-05	0.000758	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	1.94e-05	0.000758	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	1.9e-05	0.000739	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	1.88e-05	0.000733	CbGpPWpGaD
Omeprazole—ABCB1—head—head and neck cancer	1.87e-05	0.00501	CbGeAlD
Omeprazole—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	1.87e-05	0.000729	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	1.85e-05	0.000723	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—UROD—head and neck cancer	1.81e-05	0.000707	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—DPYD—head and neck cancer	1.78e-05	0.000693	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—UROD—head and neck cancer	1.77e-05	0.00069	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.76e-05	0.000685	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—DPYD—head and neck cancer	1.73e-05	0.000674	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.72e-05	0.00067	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	1.69e-05	0.000661	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—YAP1—head and neck cancer	1.69e-05	0.000658	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	1.67e-05	0.000652	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—UROD—head and neck cancer	1.67e-05	0.00065	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—UROD—head and neck cancer	1.65e-05	0.000645	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—YAP1—head and neck cancer	1.64e-05	0.00064	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	1.61e-05	0.000626	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.59e-05	0.000619	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	1.58e-05	0.000618	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.58e-05	0.000615	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.57e-05	0.000613	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.56e-05	0.000609	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NAT2—head and neck cancer	1.49e-05	0.000583	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.46e-05	0.000571	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—UROD—head and neck cancer	1.41e-05	0.000551	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.41e-05	0.000549	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NAT2—head and neck cancer	1.36e-05	0.00053	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.35e-05	0.000526	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—DPYD—head and neck cancer	1.31e-05	0.000511	CbGpPWpGaD
Omeprazole—ABCB1—lymph node—head and neck cancer	1.31e-05	0.00351	CbGeAlD
Omeprazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.31e-05	0.00051	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.29e-05	0.000505	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.29e-05	0.000503	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.28e-05	0.0005	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.28e-05	0.000498	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—YAP1—head and neck cancer	1.24e-05	0.000485	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.24e-05	0.000483	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.23e-05	0.000481	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.22e-05	0.000477	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—DPYD—head and neck cancer	1.19e-05	0.000465	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—TYMS—head and neck cancer	1.17e-05	0.000456	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.16e-05	0.000452	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.000451	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—YAP1—head and neck cancer	1.13e-05	0.000441	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GPX1—head and neck cancer	1.11e-05	0.000432	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.1e-05	0.000429	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.000428	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.1e-05	0.000427	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—UROD—head and neck cancer	1.09e-05	0.000425	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.07e-05	0.000419	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—TYMS—head and neck cancer	1.01e-05	0.000395	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GSTM1—head and neck cancer	1e-05	0.00039	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.94e-06	0.000388	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—TYMS—head and neck cancer	9.85e-06	0.000384	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.77e-06	0.000381	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GSTM1—head and neck cancer	9.74e-06	0.00038	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	9.6e-06	0.000374	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GPX1—head and neck cancer	9.58e-06	0.000374	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP1A1—head and neck cancer	9.49e-06	0.00037	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.34e-06	0.000364	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GPX1—head and neck cancer	9.32e-06	0.000364	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP1A1—head and neck cancer	9.23e-06	0.00036	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NAT2—head and neck cancer	9.2e-06	0.000359	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.01e-06	0.000351	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.96e-06	0.000349	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.87e-06	0.000346	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	8.67e-06	0.000338	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NAT2—head and neck cancer	8.43e-06	0.000329	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.2e-06	0.00032	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.15e-06	0.000318	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—DPYD—head and neck cancer	8.07e-06	0.000315	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8e-06	0.000312	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.92e-06	0.000309	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.8e-06	0.000304	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.8e-06	0.000304	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—YAP1—head and neck cancer	7.66e-06	0.000299	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.58e-06	0.000296	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NAT2—head and neck cancer	7.53e-06	0.000294	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TYMS—head and neck cancer	7.46e-06	0.000291	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—DPYD—head and neck cancer	7.4e-06	0.000288	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTM1—head and neck cancer	7.38e-06	0.000288	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NAT2—head and neck cancer	7.35e-06	0.000287	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.29e-06	0.000284	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.22e-06	0.000281	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GPX1—head and neck cancer	7.07e-06	0.000276	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—YAP1—head and neck cancer	7.02e-06	0.000274	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP1A1—head and neck cancer	6.99e-06	0.000273	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NAT2—head and neck cancer	6.92e-06	0.00027	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NAT2—head and neck cancer	6.86e-06	0.000268	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TYMS—head and neck cancer	6.79e-06	0.000265	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.77e-06	0.000264	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTM1—head and neck cancer	6.71e-06	0.000262	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—DPYD—head and neck cancer	6.6e-06	0.000257	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.55e-06	0.000255	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—head and neck cancer	6.52e-06	0.000254	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—DPYD—head and neck cancer	6.44e-06	0.000251	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GPX1—head and neck cancer	6.43e-06	0.000251	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A1—head and neck cancer	6.36e-06	0.000248	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—YAP1—head and neck cancer	6.26e-06	0.000244	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.23e-06	0.000243	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.17e-06	0.000241	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—YAP1—head and neck cancer	6.11e-06	0.000238	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—DPYD—head and neck cancer	6.07e-06	0.000237	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—DPYD—head and neck cancer	6.02e-06	0.000235	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NAT2—head and neck cancer	5.87e-06	0.000229	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—YAP1—head and neck cancer	5.76e-06	0.000225	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.75e-06	0.000224	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.75e-06	0.000224	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—YAP1—head and neck cancer	5.71e-06	0.000223	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—head and neck cancer	5.69e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—head and neck cancer	5.64e-06	0.00022	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.53e-06	0.000216	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—head and neck cancer	5.49e-06	0.000214	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.27e-06	0.000206	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—DPYD—head and neck cancer	5.14e-06	0.000201	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.02e-06	0.000196	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—head and neck cancer	4.92e-06	0.000192	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—YAP1—head and neck cancer	4.88e-06	0.00019	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—head and neck cancer	4.79e-06	0.000187	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.71e-06	0.000184	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.6e-06	0.000179	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—head and neck cancer	4.6e-06	0.000179	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—head and neck cancer	4.54e-06	0.000177	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NAT2—head and neck cancer	4.53e-06	0.000177	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GPX1—head and neck cancer	4.35e-06	0.00017	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.29e-06	0.000167	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—head and neck cancer	4.21e-06	0.000164	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—head and neck cancer	4.17e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—head and neck cancer	4.16e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.11e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—head and neck cancer	4.01e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPX1—head and neck cancer	3.99e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DPYD—head and neck cancer	3.97e-06	0.000155	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.95e-06	0.000154	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—head and neck cancer	3.78e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—YAP1—head and neck cancer	3.77e-06	0.000147	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—head and neck cancer	3.76e-06	0.000147	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.74e-06	0.000146	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—head and neck cancer	3.72e-06	0.000145	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—head and neck cancer	3.67e-06	0.000143	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.67e-06	0.000143	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—head and neck cancer	3.63e-06	0.000142	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—head and neck cancer	3.63e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPX1—head and neck cancer	3.56e-06	0.000139	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.54e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.53e-06	0.000137	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPX1—head and neck cancer	3.48e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—head and neck cancer	3.47e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—head and neck cancer	3.46e-06	0.000135	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.44e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—head and neck cancer	3.43e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.42e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.39e-06	0.000132	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—head and neck cancer	3.38e-06	0.000132	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—head and neck cancer	3.3e-06	0.000129	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—head and neck cancer	3.28e-06	0.000128	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPX1—head and neck cancer	3.28e-06	0.000128	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPX1—head and neck cancer	3.25e-06	0.000127	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.24e-06	0.000127	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.24e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.21e-06	0.000125	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.2e-06	0.000125	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—head and neck cancer	2.93e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.9e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.9e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—head and neck cancer	2.84e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPX1—head and neck cancer	2.77e-06	0.000108	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—head and neck cancer	2.76e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.75e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.64e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—head and neck cancer	2.56e-06	9.99e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—head and neck cancer	2.56e-06	9.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.35e-06	9.16e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—head and neck cancer	2.33e-06	9.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—head and neck cancer	2.26e-06	8.82e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.26e-06	8.8e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.24e-06	8.72e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—head and neck cancer	2.23e-06	8.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPX1—head and neck cancer	2.14e-06	8.35e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.12e-06	8.27e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.1e-06	8.18e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—head and neck cancer	2.09e-06	8.15e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—head and neck cancer	2.05e-06	7.99e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—head and neck cancer	2.05e-06	7.98e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.93e-06	7.52e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.91e-06	7.45e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—head and neck cancer	1.9e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—head and neck cancer	1.83e-06	7.13e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—head and neck cancer	1.78e-06	6.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—head and neck cancer	1.68e-06	6.56e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—head and neck cancer	1.67e-06	6.5e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.63e-06	6.37e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—head and neck cancer	1.58e-06	6.15e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.44e-06	5.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—head and neck cancer	1.42e-06	5.56e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.29e-06	5.03e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—head and neck cancer	1.29e-06	5.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.26e-06	4.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.26e-06	4.91e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.19e-06	4.63e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—head and neck cancer	1.18e-06	4.6e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.18e-06	4.59e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—head and neck cancer	1.1e-06	4.29e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—head and neck cancer	1.05e-06	4.11e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—head and neck cancer	1.03e-06	4.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1e-06	3.92e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—head and neck cancer	9.69e-07	3.78e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—head and neck cancer	9.61e-07	3.75e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—head and neck cancer	8.21e-07	3.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.76e-07	3.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—head and neck cancer	6.34e-07	2.47e-05	CbGpPWpGaD
